Judy Henry: From Herbalist to Entrepreneur

Sep.08.2022
Judy Henry: From Herbalist to Entrepreneur
Judy Henry, Idaho entrepreneur, developed all-natural formulas mimicking addictive nicotine and SARMS, but is unable to sell due to FDA regulations.

Judy Henry, an entrepreneur from Idaho, USA, has had a lifelong passion for plants and herbs. She spent several years researching the benefits of herbal medicine for health and has developed it into a lifelong career.


I use plant-based products because I grew up with them and understand what they can do for our bodies," Henry said during the interview.


I truly believe that God has placed everything we need on this earth," she continued. "They are the culmination of knowledge from previous generations who embraced plant medicine because of the powerful impact it has on our overall well-being.


This belief guides the life of Judy Henry. Furthermore, this belief has developed into something unique for her. Sacred Body Botanicals is the result of her dedication. Her accomplishment is building a small, natural health and wellness brand, which ultimately grew into a laboratory for innovative products developed over the years.


As a former smoker, Henry saw an opportunity to improve health. Utilizing her expertise in herbal medicine, she created a series of all-natural formulas to mimic the pleasure of addictive nicotine. Henry patented several of these formulas, stating that they have attracted a broad customer base who have seen benefits in a short period of time.


One of the products is a nicotine-free e-liquid, which Henry claims is a nicotine detoxifier that can help people quit smoking.


She developed the NoNic product, which has had a promising start. She also launched a pilot program in the local community to offer workshops introducing customers to her NoNic product.


She said she has had success introducing her NoNic formula to clients struggling with nicotine addiction in a few short meetings. Henry pointed out that due to FDA regulations, the product has not undergone medical review and she cannot promote its health benefits. However, she said some of her clients have provided positive feedback. One story she shared with me was particularly notable. A gentleman started using the NoNic formula and claimed he immediately became addicted to it, never smoking again. She has seen real-life success with NoNic.


However, the harsh reality is that selling plant-based formulations in the United States is illegal without invasive and expensive FDA inspections and approvals or other bans on products not federally approved. Despite creating a product that is almost entirely different from others on the market, the law forbids Henry from selling NoNic through her company, Sacred Body Botanicals.


In 2020, the United States Congress passed the controversial Preventing Online Sales of E-Cigarettes to Children Act, which amended the Prevent All Cigarette Trafficking (PACT) Act of 2009. The new law allows the Federal Alcohol, Tobacco, and Firearms (ATF) agency to actively enforce rules governing the interstate sale of tobacco products. The Preventing Online Sales of E-Cigarettes to Children Act expands upon the existing PACT Act by including a broad definition that encompasses e-cigarette devices and includes a ban on e-cigarette mailings enforced by the United States Postal Service.


Disclaimer: 1. This article is compiled from third-party information, and is only provided for industry exchange and learning purposes. 2. This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of the article content. The compilation of this article is only for industry exchange and research. 3. Due to the limitations of compilation skills, the compiled article may not express the same meaning as the original text. Please refer to the original text for accuracy. 4. Regarding any domestic, Hong Kong, Macau, Taiwan, or foreign statements and positions, 2FIRSTS fully aligns with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
At InterTabac 2026, nicotine pouch growth was visible not only in brands but across equipment, raw materials and OEM manufacturing. 2Firsts interviewed AIRSCREAM commercial head Steve Moore on how many pouch factories Europe may ultimately need and where manufacturers can differentiate, from formulation and flavour to pouch materials, production consistency and customer service. The category continues to expand, but questions remain over future capacity, consolidation and the long-term structure of the supply chain.
Sep.18
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Japan Tobacco International (JTI) has introduced PERLZ nicotine pearls in the UK, expanding its oral nicotine portfolio beyond conventional nicotine pouches. The fully dissolvable, multi-layer pearls are placed under the tongue and come in Mint and Berry flavors at concentrations of 1mg/g and 2mg/g, equivalent to approximately 0.3mg and 0.5mg of nicotine per pearl. UK retailer Haypp published four 30-pearl dispenser listings on July 31, 2026, followed by three 10-pearl sachet products on August 17. The dispensers retail for £6.50, while the sachets cost £2.50.
product
Oct.12
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Japan Tobacco Inc. (JT) launched three limited-edition autumn tobacco sticks for its Ploom heated tobacco devices in Japan on October 16, 2026, under the EVO, MEVIUS and CAMEL brands. All three are regular tobacco variants with seasonal packaging. Each pack contains 20 sticks, priced at ¥620, ¥590 and ¥570, respectively, including tax. The products are compatible with all Ploom devices and are sold in limited quantities exclusively through the CLUB JT online store while supplies last.
product
Oct.20
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Former cigarette smokers accounted for an estimated 54% of current e-cigarette users in Great Britain in 2025, while 26% also smoked cigarettes and 20% had never regularly smoked, according to a 2Firsts analysis of Office for National Statistics (ONS) data. Among former cigarette smokers who currently vape, approximately 81% used e-cigarettes daily, compared with about 50% of dual users. The ONS found that 33.8% of current cigarette smokers also vaped in 2025, up from 10.6% in 2014. Approximately 1.1 million adults who had never regularly smoked cigarettes used e-cigarettes, representing 2.9% of that population, compared with 0.2% in 2014. The figures highlight differences in the composition, frequency of use and long-term trends across Britain's vaping population.
DATA
Oct.14
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24